We investigated this by knockdown of SWI/SNF complex members in the colon cancer cell line HCT116, which harbours an activating KRAS G13D mutation (KRASG13D/+), and in a derived cell line in which the mutant KRAS allele was deleted (KRASKO/+). This evidence concerns the gene KRAS and colonic neoplasm.